Due to myocardial I/R, STAT3 upregulates the expression of Bcl-2, Bcl-xl, and other genes, which have been shown to reduce cell death and lessen adverse cardiac remodeling after myocardial infarction (Yang et al., 2013b). The gene discussed is BCL2; the disease is myocardial infarction.